Haddad A, Golan-Lev T, Benvenisty N, Goldberg M
Mol Med. 2025; 31(1):97.
PMID: 40082762
PMC: 11907909.
DOI: 10.1186/s10020-025-01141-5.
Su J, Zhou H, Zhang Z, Zhou X, Zou Q, Li S
Acta Pharmacol Sin. 2025; .
PMID: 40055528
DOI: 10.1038/s41401-025-01514-w.
ODonohue A, Ginn S, Burgio G, Berman Y, Dabscheck G, Schindeler A
Mol Ther Nucleic Acids. 2025; 36(1):102475.
PMID: 40034205
PMC: 11872496.
DOI: 10.1016/j.omtn.2025.102475.
Lei J, Chen J, Yu W, Wu Q, Jing S, Tang Y
Front Cell Dev Biol. 2025; 12:1516613.
PMID: 39949609
PMC: 11821962.
DOI: 10.3389/fcell.2024.1516613.
Chen H, Xu Y, Chen D, Xiao D, Yang B, Wang W
BMC Cancer. 2025; 25(1):223.
PMID: 39920630
PMC: 11806854.
DOI: 10.1186/s12885-025-13661-8.
WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by loss of function.
Wang X, Zhu R, Yu P, Qi S, Zhong Z, Jin R
Sci Adv. 2025; 11(4):eadp4765.
PMID: 39841844
PMC: 11753430.
DOI: 10.1126/sciadv.adp4765.
Frontal lobe intra-axial schwannoma harboring a CHD7::VGLL3 fusion and heterozygous TSC2 p.F1510del mutation in a young child.
Nguyen A, Berger B, Abdullaev Z, Gearhart S, Castro-Echeverry E, Aldape K
Mol Biol Rep. 2025; 52(1):112.
PMID: 39792305
PMC: 11723850.
DOI: 10.1007/s11033-024-10201-8.
Dietary Palmitic Acid Drives a Palmitoyltransferase ZDHHC15-YAP Feedback Loop Promoting Tumor Metastasis.
Wang J, Shen D, Jiang J, Hu L, Fang K, Xie C
Adv Sci (Weinh). 2024; 12(6):e2409883.
PMID: 39686664
PMC: 11809420.
DOI: 10.1002/advs.202409883.
Functional annotation of the Hippo pathway somatic mutations in human cancers.
Han H, Huang Z, Xu C, Seo G, An J, Yang B
Nat Commun. 2024; 15(1):10106.
PMID: 39572544
PMC: 11582751.
DOI: 10.1038/s41467-024-54480-y.
Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders.
Han J, Zhang J, Zhang X, Luo W, Liu L, Zhu Y
Stem Cell Res Ther. 2024; 15(1):386.
PMID: 39468616
PMC: 11520482.
DOI: 10.1186/s13287-024-04011-9.
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.
Haripriya E, Hemalatha K, Matada G, Pal R, Das P, Ashadul Sk M
Mol Divers. 2024; .
PMID: 39436581
DOI: 10.1007/s11030-024-11009-1.
The Multifaceted Roles of Hippo-YAP in Cardiovascular Diseases.
Wu H, Che Y, Lan Q, He Y, Liu P, Chen M
Cardiovasc Toxicol. 2024; 24(12):1410-1427.
PMID: 39365552
DOI: 10.1007/s12012-024-09926-6.
CircPOLA2 sensitizes non-small cell lung cancer cells to ferroptosis and suppresses tumorigenesis via the Merlin-YAP signaling pathway.
Xu K, Wei G, Qi W, Ye C, Liu Y, Wang S
iScience. 2024; 27(9):110832.
PMID: 39310771
PMC: 11416675.
DOI: 10.1016/j.isci.2024.110832.
Retinoic acid-induced protein 14 links mechanical forces to Hippo signaling.
Jeong W, Kwon H, Park S, Lee I, Jho E
EMBO Rep. 2024; 25(9):4033-4061.
PMID: 39160347
PMC: 11387738.
DOI: 10.1038/s44319-024-00228-0.
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer.
Klingbeil O, Skopelitis D, Tonelli C, Yoshimoto T, Alpsoy A, Panepinto M
Cancer Discov. 2024; 14(12):2471-2488.
PMID: 39058094
PMC: 11609825.
DOI: 10.1158/2159-8290.CD-23-1529.
FRMD6 determines the cell fate towards senescence: involvement of the Hippo-YAP-CCN3 axis.
Park J, Lee S, Baek M, Lee O, Nam S, Kim J
Cell Death Differ. 2024; 31(11):1398-1409.
PMID: 38926528
PMC: 11519602.
DOI: 10.1038/s41418-024-01333-2.
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.
Xu D, Yin S, Shu Y
NPJ Precis Oncol. 2024; 8(1):133.
PMID: 38879686
PMC: 11180135.
DOI: 10.1038/s41698-024-00627-5.
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4.
Parrish A, Arora S, Thirimanne H, Rudoy D, Schmid S, Sievers P
bioRxiv. 2024; .
PMID: 38854109
PMC: 11160807.
DOI: 10.1101/2024.05.30.596719.
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.
Yuan R, Wang B, Wang Y, Liu P
Oncol Ther. 2024; 12(2):257-276.
PMID: 38760612
PMC: 11187037.
DOI: 10.1007/s40487-024-00279-2.
A PAK family kinase and the Hippo/Yorkie pathway modulate WNT signaling to functionally integrate body axes during regeneration.
Doddihal V, Mann Jr F, Ross E, McKinney M, Guerrero-Hernandez C, Brewster C
Proc Natl Acad Sci U S A. 2024; 121(20):e2321919121.
PMID: 38713625
PMC: 11098123.
DOI: 10.1073/pnas.2321919121.